Abstract:Current drug development techniques are expensive and inefficient, partially due to the use of preclinical models that do not accurately recapitulate in vivo drug efficacy and cytotoxicity. To address this challenge, we report on an integrated, in vitro multi-organoid system that enables parallel assessment of drug efficiency and toxicity on multiple 3D tissue organoids. Built in a low-cost, adhesive film-based microfluidic device, these miniaturized structures require less than 200 µL fluid volume and are amenable to both matrix-based 3D cell culture and spheroid aggregate integration, each supported with an in situ photocrosslinkable hyaluronic acid hydrogel. Here, we demonstrate this technology first with a three-organoid device consisting of liver, cardiac, and lung constructs. We show that these multiple tissue types can be kept in common circulation with high viability for 21 days and validate the platform by investigating liver metabolism of the prodrug capecitabine into 5-fluorouracil (5-FU) and observing downstream toxicity in lung and cardiac organoids. Then we expand the integrated system to accommodate six humanized constructs, including liver, cardiac, lung, endothelium, brain, and testes organoids. Following a 14-day incubation in common media, we demonstrate multi-tissue interactions by metabolizing the alkylating prodrug ifosfamide in the liver organoid to produce chloroacetaldehyde and induce downstream neurotoxicity. Our results establish an expandable, multi-organoid body-on-a-chip system that can be fabricated easily and used for the accurate characterization of drug interactions in vitro. STATEMENT OF SIGNIFICANCE: The use of 3-dimensional (3D) in vitro models in drug development has advanced over the past decade. However, with several exceptions, the majority of research studies using 3D in vitro models, such as organoids, employ single tissue types, in isolated environments with no "communication" between different tissues. This is a significant limiting factor because in the human body there is significant signaling between different cells, tissues, and organs. Here we employ a low-cost, adhesive film-based microfluidic device approach, paired with a versatile extracellular matrix-derived hyaluronic acid hydrogel to support integrated systems of 3 and 6 3D organoid and cell constructs. Moreover, we demonstrate an integrated response to drugs, in which downstream toxicity is dependent on the presence of liver organoids.

Droplet-engineered Organoids Recapitulate Parental Tissue Transcriptome with Inter-Organoid Homogeneity and Inter-Tumor Cell Heterogeneity

Microfluidic Droplet Encapsulation-Guided Organoid Growth Promotes Parental Tumor Phenotype Recapitulation

An integrated transcriptomic cell atlas of human endoderm-derived organoids

An Automated Organoid Platform With Inter-Organoid Homogeneity And Inter-Patient Heterogeneity

Development of a High-Throughput Micropatterned Agarose Scaffold for Consistent and Reproducible Hpsc-Derived Liver Organoids.

Organoid technology for tissue engineering

Organoids: An intermediate modeling platform in precision oncology.

Organoids: approaches and utility in cancer research

Highly reproducible and cost-effective one-pot organoid differentiation using a novel platform based on PF-127 triggered spheroid assembly

Organoids: development and applications in disease models, drug discovery, precision medicine, and regenerative medicine

Patient-derived organoids in precision cancer medicine

Organoids: Principle, Application and Perspective

Lamination-based Organoid Spatially Resolved Transcriptomics Technique for Primary Lung and Liver Organoid Characterization.

Meta-analysis of single-cell RNA sequencing co-expression in human neural organoids reveals their high variability in recapitulating primary tissue

Advances in Microfluidic Technologies in Organoid Research

Probing prodrug metabolism and reciprocal toxicity with an integrated and humanized multi-tissue organ-on-a-chip platform

Organoids in concert: engineering in vitro models toward enhanced fidelity

High-throughput solutions in tumor organoids: From culture to drug screening

Liver Organoids: Established Tools for Disease Modeling and Drug Development

Patient-derived organoids in human cancer: a platform for fundamental research and precision medicine

Human Organoids for Predictive Toxicology Research and Drug Development